BRIEF-UCB and Amgen announce results from several exploratory analyses of Phase 2 study of romosozumab By: Reuters: Company News September 16, 2014 at 01:40 AM EDT * UCB and Amgen announce results from several exploratory analyses of Phase 2 study of romosozumab Read More >> Related Stocks: Amgen